Retraction notice to “Engineering of dopamine conjugated with bovine serum albumin and zeolite imidazole framework: A promising drug delivery nanocarrier on lung cancer cells” [Heliyon 10 (2024) e36580]

This article has been retracted: please see Elsevier policy on article withdrawal (https://www.elsevier.com/about/policies-and-standards/article-withdrawal).This article has been retracted at the request of the Editor.An investigation conducted on behalf of the journal by Elsevier's Research In...

Full description

Saved in:
Bibliographic Details
Main Authors: Chenggang Lei, Di Liu, Qian Zhou, Shengwei Ma, Haiyun Qian
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Heliyon
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844025003871
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832573051895545856
author Chenggang Lei
Di Liu
Qian Zhou
Shengwei Ma
Haiyun Qian
author_facet Chenggang Lei
Di Liu
Qian Zhou
Shengwei Ma
Haiyun Qian
author_sort Chenggang Lei
collection DOAJ
description This article has been retracted: please see Elsevier policy on article withdrawal (https://www.elsevier.com/about/policies-and-standards/article-withdrawal).This article has been retracted at the request of the Editor.An investigation conducted on behalf of the journal by Elsevier's Research Integrity & Publishing Ethics team found phrases that make some passages in the article difficult to parse. The authors were requested to explain the use of these passages of text but were unable to do so. The Editor has lost confidence in the findings of the article and has determined that it should be retracted.The authors have not responded to the retraction notice.
format Article
id doaj-art-06516b1b4d9044799af364a1118cdb9e
institution Kabale University
issn 2405-8440
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj-art-06516b1b4d9044799af364a1118cdb9e2025-02-02T05:28:46ZengElsevierHeliyon2405-84402025-01-01112e42007Retraction notice to “Engineering of dopamine conjugated with bovine serum albumin and zeolite imidazole framework: A promising drug delivery nanocarrier on lung cancer cells” [Heliyon 10 (2024) e36580]Chenggang Lei0Di Liu1Qian Zhou2Shengwei Ma3Haiyun Qian4Department of Cardiothoracic Surgery, Jingzhou Hospital Affiliated to Yangtze University, No.26, Chuyuan Road, Jingzhou District, Jingzhou City, Hubei Province, 434020, ChinaDepartment of Cardiothoracic Surgery, Jingzhou Hospital Affiliated to Yangtze University, No.26, Chuyuan Road, Jingzhou District, Jingzhou City, Hubei Province, 434020, ChinaDepartment of Cardiothoracic Surgery, Jingzhou Hospital Affiliated to Yangtze University, No.26, Chuyuan Road, Jingzhou District, Jingzhou City, Hubei Province, 434020, ChinaDepartment of Cardiothoracic Surgery, Jingzhou Hospital Affiliated to Yangtze University, No.26, Chuyuan Road, Jingzhou District, Jingzhou City, Hubei Province, 434020, ChinaCorresponding author.; Department of Cardiothoracic Surgery, Jingzhou Hospital Affiliated to Yangtze University, No.26, Chuyuan Road, Jingzhou District, Jingzhou City, Hubei Province, 434020, ChinaThis article has been retracted: please see Elsevier policy on article withdrawal (https://www.elsevier.com/about/policies-and-standards/article-withdrawal).This article has been retracted at the request of the Editor.An investigation conducted on behalf of the journal by Elsevier's Research Integrity & Publishing Ethics team found phrases that make some passages in the article difficult to parse. The authors were requested to explain the use of these passages of text but were unable to do so. The Editor has lost confidence in the findings of the article and has determined that it should be retracted.The authors have not responded to the retraction notice.http://www.sciencedirect.com/science/article/pii/S2405844025003871
spellingShingle Chenggang Lei
Di Liu
Qian Zhou
Shengwei Ma
Haiyun Qian
Retraction notice to “Engineering of dopamine conjugated with bovine serum albumin and zeolite imidazole framework: A promising drug delivery nanocarrier on lung cancer cells” [Heliyon 10 (2024) e36580]
Heliyon
title Retraction notice to “Engineering of dopamine conjugated with bovine serum albumin and zeolite imidazole framework: A promising drug delivery nanocarrier on lung cancer cells” [Heliyon 10 (2024) e36580]
title_full Retraction notice to “Engineering of dopamine conjugated with bovine serum albumin and zeolite imidazole framework: A promising drug delivery nanocarrier on lung cancer cells” [Heliyon 10 (2024) e36580]
title_fullStr Retraction notice to “Engineering of dopamine conjugated with bovine serum albumin and zeolite imidazole framework: A promising drug delivery nanocarrier on lung cancer cells” [Heliyon 10 (2024) e36580]
title_full_unstemmed Retraction notice to “Engineering of dopamine conjugated with bovine serum albumin and zeolite imidazole framework: A promising drug delivery nanocarrier on lung cancer cells” [Heliyon 10 (2024) e36580]
title_short Retraction notice to “Engineering of dopamine conjugated with bovine serum albumin and zeolite imidazole framework: A promising drug delivery nanocarrier on lung cancer cells” [Heliyon 10 (2024) e36580]
title_sort retraction notice to engineering of dopamine conjugated with bovine serum albumin and zeolite imidazole framework a promising drug delivery nanocarrier on lung cancer cells heliyon 10 2024 e36580
url http://www.sciencedirect.com/science/article/pii/S2405844025003871
work_keys_str_mv AT chengganglei retractionnoticetoengineeringofdopamineconjugatedwithbovineserumalbuminandzeoliteimidazoleframeworkapromisingdrugdeliverynanocarrieronlungcancercellsheliyon102024e36580
AT diliu retractionnoticetoengineeringofdopamineconjugatedwithbovineserumalbuminandzeoliteimidazoleframeworkapromisingdrugdeliverynanocarrieronlungcancercellsheliyon102024e36580
AT qianzhou retractionnoticetoengineeringofdopamineconjugatedwithbovineserumalbuminandzeoliteimidazoleframeworkapromisingdrugdeliverynanocarrieronlungcancercellsheliyon102024e36580
AT shengweima retractionnoticetoengineeringofdopamineconjugatedwithbovineserumalbuminandzeoliteimidazoleframeworkapromisingdrugdeliverynanocarrieronlungcancercellsheliyon102024e36580
AT haiyunqian retractionnoticetoengineeringofdopamineconjugatedwithbovineserumalbuminandzeoliteimidazoleframeworkapromisingdrugdeliverynanocarrieronlungcancercellsheliyon102024e36580